Talaris Therapeutics, Inc. Uncategorized Contracts & Agreements
14 Contracts & Agreements
- Description of Securities (Filed With SEC on March 19, 2024)
- Side Letter, dated as of November 10, 2023, by and between the Registrant and Ryan Robinson (Filed With SEC on November 14, 2023)
- Offer Letter, dated as of June 7, 2023, by and between Tourmaline Bio, Inc. and Ryan Robinson (Filed With SEC on October 20, 2023)
- Offer Letter, dated as of October 18, 2023, by and between Tourmaline Bio, Inc. and Susan Dana Jones, Ph.D (Filed With SEC on October 20, 2023)
- Offer Letter, dated as of October 18, 2023, by and between Tourmaline Bio, Inc. and Brad Middlekauff, M.D (Filed With SEC on October 20, 2023)
- Offer Letter, dated as of October 18, 2023, by and between Tourmaline Bio, Inc. and Sandeep Kulkarni, M.D (Filed With SEC on October 20, 2023)
- Strategic Advisor Agreement, by and between the Registrant and Scott Requadt, dated May 26, 2023 (Filed With SEC on July 20, 2023)
- Form of Lock-Up Agreement (Filed With SEC on June 22, 2023)
- Forms of Talaris Support Agreements (Filed With SEC on June 22, 2023)
- Form of Tourmaline Support Agreement (Filed With SEC on June 22, 2023)
- Description of Securities (Filed With SEC on March 17, 2022)
- Offer Letter, by and between the Registrant and Mary Kay Fenton, as amended, dated January 21, 2021 (Filed With SEC on April 16, 2021)
- Offer Letter, by and between the Registrant and Michael Zdanowski, dated September 29, 2020 (Filed With SEC on April 16, 2021)
- Offer Letter, by and between the Registrant and Nancy Krieger, dated November 1, 2018 (Filed With SEC on April 16, 2021)